Global Blood Transfusion Diagnostics Market: Market Research by Knowledge Sourcing Intelligence
The global blood transfusion diagnostics market is expected to reach $XX.XX billion by 2023 from US$XX.XX billion in 2017, at a CAGR of 5.48%. Blood transfusion diagnostics include the instruments that are used to screen and conduct tests before transfusion of blood and blood products from donor to recipient. Increasing number of infectious diseases coupled with growing demand for blood and blood component transfusions owing to a large patient population base suffering from chronic diseases such as aplastic anemia, thalassemia, and leukemia are some of the major drivers attracting numerous market players to invest in and develop blood transfusion diagnostics technologies.
 |
| Global Blood Transfusion Diagnostics Market Forecast, 2017-2023, US$ Billion |
Global Blood Transfusion Diagnostics Market by Technology:
By technology, the blood transfusion diagnostics market is segmented as ELISA, Western Blotting, Nucleic Acid Amplification and Others. ELISA is expected to own a significant share owing to its cost effectiveness coupled with the accurate diagnosis of various transfusion transmitted infections. Nucleic Acid Amplification tests will also show a significant growth owing to high sensitivity and specificity for viral nucleic acid.The market for blood transfusion diagnostics by nucleic acid amplification test (NAT) technology is estimated to show significant growth during the forecast period. The market is projected to grow at a CAGR of XX.XX%, increasing from US$XX.XX billion in 2017 to US$XX.XX billion in 2023. The high adoption rate of Nucleic acid testing (NAT) for screening blood donations to reduce the risk of transfusion transmitted infections (TTIs) in the recipients, thus providing an additional layer of blood safety is a major factor complementing this growth. The market research provides a detailed analysis of global blood transfusion diagnostics market on the basis of various segment like- By Technology, By Geography, By End-user etc.
 |
| Sample view of Global Blood Transfusion Diagnostics Market Share by Technology |
Global Blood Transfusion Diagnostics Market by Geography:
Geographically, global blood transfusion diagnostics market is segmented as North America, South America, Europe, Middle East and Africa, and Asia-Pacific. North America presently holds a significant market share of XX.XX% owing to the rising number of cancer patients and other blood related diseases in the region. South America and Middle East and Africa regional markets will witness a considerable CAGR of XX.XX% and XX.XX% respectively during the projected period owing to the rising number of organ transplants in these regions. Regulatory alteration in France and UK allowing larger proportion of population to donate blood along with rising road accidents is driving the market in Europe with Europe currently holding XX% share of the market. While, growing healthcare expenditure and increasing blood donations is driving the blood transfusion diagnostics market in APAC.
global blood transfusion diagnostics market size
For our Healthcare Industry coverage:
global blood transfusion diagnostics industry trends
In addition,Rising number of the diagnostic laboratories around the globe are expected to boost the blood transfusion diagnostics market growth during the given time frame. Rising number of collaborations between hospitals and diagnostic laboratories will further augment the growth of the market.
Comments
Post a Comment